title: Diacylglycerol-induced shape changes, movements and altered F-actin distribution in human neutrophils.
abstract: The study shows that diacylglycerols (DAGs) as physiological activators of protein kinase C induce characteristic shape changes in human neutrophil granulocytes. In contrast to chemotactic peptides, which can induce front-tail polarity characterized by a contracted tail and an expanding front, DAGs elicit the formation of non-polar cells with surface projections. These cells exhibit a distinct type of motility characterized by vigorous and continuous shape changes without front-tail polarity and without the unidirectional movement and cytoplasmic streaming seen in polarized cells. In neutrophils exposed to DAGs, F-actin is shifted to the cell periphery and mainly into the surface projections of activated cells. DAGs induce the formation of large intracellular vacuoles in neutrophils producing surface projections, and these vacuoles persist after the cells have reacquired a spherical shape. Combined stimulation of human neutrophils with DAG and fNLPNTL results in a suppression of peptide-induced polarity and the formation of non-polar motile cells resembling those stimulated with DAG alone. These results suggest that the diacylglycerol-protein kinase C pathway may be instrumental in transducing or modulating signals to both the locomotor apparatus and the exocytotic and/or pinocytic system of the cell. Neutrophil stimulation with DAGs thus represents a useful model with which to study further the hypothesis that distinct types of neutrophil shapes and movements are preferentially associated with distinct functions and to characterize signalling pathways.
authors.affiliation: Institute of Pathology, University of Bern, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Zimmermann
authors.forename: P
authors.initials: P
authors.lastname: Gehr
authors.forename: H U
authors.initials: HU
authors.lastname: Keller
mesh_terms: D000199:Actins / Q000378:metabolism*; D002465:Cell Movement / Q000187:drug effects; D002634:Chemotaxis, Leukocyte; D004075:Diglycerides / Q000494:pharmacology*; D005989:Glycerides / Q000494:pharmacology*; D006801:Humans; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure
chemical_list: D000199:Actins; D004075:Diglycerides; D005989:Glycerides